Contributors |
|
xix | |
Abbreviations |
|
xxiii | |
Overview: a panel discussion: critical topics in the neurology of AIDS |
|
1 | (11) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Priorities of the National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke for neuroAIDS research in resource-limited countries |
|
12 | (5) |
|
|
|
HIV-1 biology, immunology, and neurovirulence |
|
|
|
The molecular biology of HIV-1 |
|
|
17 | (12) |
|
|
|
|
|
29 | (20) |
|
|
|
|
HIV-1 structural and regulatory proteins and neurotoxicity |
|
|
49 | (8) |
|
Mariantoinetta Di Stefano |
|
|
|
|
The genetic bases of HIV-1 neuropathogenesis |
|
|
57 | (14) |
|
|
|
Innate and acquired immunity in HIV-1 dementia |
|
|
|
Mononuclear phagocyte heterogeneity and the blood-brain barrier: a model for HIV-1 neuropathogenesis |
|
|
71 | (14) |
|
|
|
|
|
Common immune pathways of neural injury in neurodegenerative disorders |
|
|
85 | (10) |
|
|
|
|
95 | (12) |
|
|
|
The blood--brain barrier and HIV-1 |
|
|
|
The blood--brain barrier: its structure and function |
|
|
107 | (8) |
|
|
The blood--brain barrier as an immunocompetent organ |
|
|
115 | (10) |
|
|
Viral receptors and the mechanisms of HIV-1 entry into cells and the central nervous system |
|
|
125 | (22) |
|
|
Francisco Gonzalez-Scarano |
|
|
Mechanisms of viral entry through the blood-brain barrier |
|
|
147 | (8) |
|
|
|
The blood--brain barrier: monocyte and viral entry into the brain |
|
|
155 | (8) |
|
|
The choroid plexus and viral entry into the brain |
|
|
163 | (14) |
|
|
|
|
|
|
Mechanisms of neurotoxicity by HIV-1 and cellular immune products |
|
|
|
Mechanisms of macrophage-mediated neurotoxicity |
|
|
177 | (4) |
|
|
Chemokines, HIV-1, and the central nervous system |
|
|
181 | (12) |
|
|
Mechanisms of neuronal demise in HIV dementia: role of HIV-1 Tat |
|
|
193 | (8) |
|
|
|
Protection against HIV-1 gp 120 and HIV-1 Tat neurotoxicity |
|
|
201 | (10) |
|
|
|
|
|
|
|
211 | (14) |
|
|
|
Transcriptional analysis of inflammatory and glial responses in the central nervous system: development of RNA fingerprints for neuroAIDS and other central nervous system disorders |
|
|
225 | (14) |
|
|
|
Neurogenesis and its links to brain development, developmental therapeutics, and the pathogenesis of neurodegenerative disorders including HIV-1-associated dementia |
|
|
239 | (18) |
|
|
|
|
|
|
|
The simian immunodeficiency virus/macaque model: detailing viral weapons and host defenses in HIV central nervous system disease |
|
|
257 | (12) |
|
|
|
|
|
|
|
The feline immunodeficiency virus model of HIV-1-associated neurological disease |
|
|
269 | (10) |
|
|
|
Neurological disease produced by maedi--visna and caprine arthritis--encephalitis viruses, lentiviruses of sheep and goats |
|
|
279 | (10) |
|
|
Sigurbjorg Torsteinsdottir |
|
|
|
Murine model systems for studies of HIV-1-associated dementia |
|
|
289 | (8) |
|
|
Studies of adaptive immunity in a murine model of HIV-1 encephalitis |
|
|
297 | (12) |
|
|
|
|
Laboratory model systems of drug abuse and their relevance to HIV infection and dementia |
|
|
309 | (14) |
|
|
|
|
|
|
|
Living with HIV and AIDS (clinical perspectives from patients living with the neurological consequences of HIV infection) |
|
|
|
HIV dementia: living with the suffering, the diagnosis, and the uncertainties |
|
|
323 | (2) |
|
|
Neurological manifestations of HIV disease |
|
|
325 | (2) |
|
|
|
327 | (4) |
|
|
Living with HIV in an African community: a mental health point of view |
|
|
331 | (4) |
|
|
|
HIV and sexual dysfunction: a patient's view |
|
|
335 | (4) |
|
|
Clinical and pathological aspects of disease |
|
|
|
An overview of the clinical and biological features of the AIDS dementia complex |
|
|
339 | (20) |
|
|
|
HIV neurocognitive disorders |
|
|
359 | (16) |
|
|
|
|
The neuropathology of HIV--associated brain disease |
|
|
375 | (18) |
|
|
Brain pathology in HIV-1-infected drug abusers |
|
|
393 | (12) |
|
|
|
Current concepts in HIV neuropathogenesis: neuronal injury, white matter disease, and neurotrophic factors |
|
|
405 | (10) |
|
|
|
|
Spinal cord disease: clinical presentations and pathology |
|
|
415 | (8) |
|
|
|
|
The spectrum of peripheral neuropathies in AIDS |
|
|
423 | (22) |
|
|
|
|
|
|
|
The neuropathology of HIV-related neuropathies |
|
|
445 | (4) |
|
|
Myopathies associated with HIV-1: clinical and pathological manifestations |
|
|
449 | (12) |
|
|
|
|
Human polyomavirus, JC virus, and progressive multifocal leukoencephalopathy |
|
|
461 | (14) |
|
|
|
|
Central nervous system neoplasms in AIDS |
|
|
475 | (10) |
|
|
|
Opportunistic infections of the nervous system in AIDS |
|
|
485 | (46) |
|
|
|
|
531 | (10) |
|
|
|
|
|
|
|
Alcohol and HIV-1 neuropathogenesis |
|
|
541 | (12) |
|
|
|
|
|
553 | (14) |
|
|
|
|
|
|
Diagnostic methods for monitoring cognitive function in neuroAIDS |
|
|
|
|
567 | (8) |
|
|
|
Magnetic resonance spectroscopy of animal models of neuroAIDS |
|
|
575 | (10) |
|
|
|
Magnetic resonance spectroscopy and functional magnetic resonance imaging in the evaluation of HIV-associated brain injury |
|
|
585 | (16) |
|
|
|
|
601 | (6) |
|
|
|
|
607 | (10) |
|
|
|
The effects of antiretroviral therapy on viral and nonviral markers in cerebrospinal fluid |
|
|
617 | (12) |
|
|
Compartmentalization of HIV infection in the central nervous system |
|
|
629 | (10) |
|
|
|
HIV-1 encephalopathy: unique aspects in children and adolescents |
|
|
|
|
639 | (20) |
|
|
Neuropathological aspects of HIV-1 infection in children |
|
|
659 | (8) |
|
|
Evaluation of neurodevelopmental deficits in children with HIV-1 infection |
|
|
667 | (16) |
|
|
|
Psychosocial aspects of neurological impairment in children with AIDS |
|
|
683 | (10) |
|
|
|
Antiretroviral therapy in children |
|
|
693 | (20) |
|
|
Antiretroviral and adjunctive drug strategies for neuroAIDS and treatment of opportunistic infections |
|
|
|
Current concepts in the treatment of HIV infection with focus on brain disease |
|
|
713 | (8) |
|
|
Treatment of opportunistic infections associated with HIV infection |
|
|
721 | (8) |
|
|
Pharmacology of antiretroviral drugs in the central nervous system: pharmacokinetics, antiretroviral resistance, and pharmacodynamics |
|
|
729 | (6) |
|
|
|
Development of adjunctive therapies for the neurological manifestations of AIDS: dementia and painful neuropathy |
|
|
735 | (8) |
|
|
|
Social and behavioral consequences of HIV infection |
|
|
|
Everyday impact of HIV-associated neurocognitive disorders |
|
|
743 | (12) |
|
|
|
|
Coping, methamphetamine, and HIV-1 |
|
|
755 | (10) |
|
|
|
Club drugs and HIV transmission |
|
|
765 | (10) |
|
|
|
Facing legal and ethical challenges in the treatment of AIDS |
|
|
775 | (12) |
|
|
|
AIDS-related death anxiety: a research review and clinical recommendations |
|
|
787 | (14) |
|
|
|
|
Clinical-neuropathological correlation in HIV in the era of highly active antiretroviral therapy |
|
|
801 | (12) |
|
|
|
|
|
Pain management in HIV infection |
|
|
813 | (10) |
|
|
Index |
|
823 | |